Erni J Nelwan is an expert in Infectiology at Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo (Indonesia). As of October 2026, ScienceLeadR ranks Erni J Nelwan in the top 1% of experts in Indonesia for Mosquito-Borne Diseases, Pneumonia and COVID-19. Erni J Nelwan has authored 144 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 555 (community average: 125). How the SLR is computed.

LeadR Profile

555 ScienceLeadR Reputation 555
Network Map

Infectiology

Subspecialties: Gastroenterology - Endocrinology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2007 - 2026

Source: PubMed

Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo

Publications Synthesis

Sources: PubMed, OpenAlex

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Risk Factors for Multi-Drug Resistance (MDR) Infections in COVID-19 Patients with Secondary Bacterial Infections.
PMID 42845067 — comorbidity, bacterial infections, pharmaceutical preparations, drug resistance, multiple, multiple chronic conditions, covid-19, risk factors, morbidity, records, history, infections, medical records, drug resistance
Acta Med Indones20260
Factors influencing antimicrobial stewardship implementation in healthcare facilities in four countries of Southeast Asia: a mixed-methods study (2022-23).
PMID 42707160 — antimicrobial stewardship, centers for disease control and prevention, u.s., therapeutics
Lancet Reg Health Southeast Asia20260
Effect of higher dose primaquine for the radical cure of Plasmodium vivax malaria in Indonesia: a systematic review and individual patient data meta-analysis.
PMID 42375875 — malaria, safety, malaria, vivax, hemolysis, primaquine
Lancet Reg Health West Pac20261
High-dose, short-course primaquine after point-of-care G6PD testing for the radical cure of Plasmodium vivax malaria: a safety study in Papua New Guinea and Indonesia.
PMID 42326839 — research design, malaria, safety, point-of-care systems, drug-related side effects and adverse reactions, malaria, vivax, primaquine, therapeutics
Lancet Reg Health West Pac20260
Dengue severity and profiles of complement activation and immune mediators: A multicenter cohort study in Indonesia.
PMID 42241399 — cohort studies, recycling, dengue, complement system proteins, complement activation
PLoS One20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 2

By phase:

Phase 2 2
N/A 1
Phase 3 1

By status:

Completed 3
Recruiting 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 1
multicentric5to9 0
multicentricup10 2

Main Topics

Cohort/Consortium Investigators 4

LeadR Networks

Main global connection map